Inhibikase Therapeutics, Inc.(IKT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IKT Inhibikase Therapeutics, Inc.

交易中 12-10 15:42:11 EST

3.24

+0.03

+0.93%

最高3.60	最低3.18	成交量26.56万
今开3.21	昨收3.21	日振幅13.08%
总市值2.18亿	流通市值3,317万	总股本6,719万
成交额88.64万	换手率2.59%	流通股本1,024万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"IKT","market":"US","secType":"STK","nameCN":"Inhibikase Therapeutics, Inc.","latestPrice":3.24,"timestamp":1733863330928,"preClose":3.21,"halted":0,"volume":265571,"delay":0,"floatShares":10237218,"shares":67192570,"eps":-2.989894,"marketStatus":"交易中","marketStatusCode":2,"change":0.03,"latestTime":"12-10 15:42:11 EST","open":3.2148,"high":3.6,"low":3.18,"amount":886446.3071622,"amplitude":0.130841,"askPrice":3.26,"askSize":500,"bidPrice":3.21,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.989894,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1733864400000},"adr":0,"listingDate":1608699600000,"adjPreClose":3.21,"preHourTrading":{"tag":"盘前","latestPrice":3.2112,"preClose":3.21,"latestTime":"08:41 EST","volume":40,"amount":128.636,"timestamp":1733838098945},"postHourTrading":{"tag":"盘后","latestPrice":3.1201,"preClose":3.21,"latestTime":"19:56 EST","volume":4303,"amount":14126.9326,"timestamp":1733792213069},"volumeRatio":0.995973},"requestUrl":"/m/hq/s/IKT","defaultTab":"news","newsList":[{"id":"2490177537","title":"Inhibikase Therapeutics, Inc.盘中异动 股价大跌5.18%报3.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490177537","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490177537?lang=zh_cn&edition=full","pubTime":"2024-12-09 22:40","pubTimestamp":1733755256,"startTime":"0","endTime":"0","summary":"北京时间2024年12月09日22时40分，Inhibikase Therapeutics, Inc.股票出现异动，股价急速下跌5.18%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209224056a1e0ad5c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209224056a1e0ad5c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","IKT","BK4139"],"gpt_icon":0},{"id":"2489048237","title":"Inhibikase Therapeutics, Inc.盘中异动 大幅拉升6.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489048237","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489048237?lang=zh_cn&edition=full","pubTime":"2024-12-06 23:57","pubTimestamp":1733500673,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日23时57分，Inhibikase Therapeutics, Inc.股票出现波动，股价快速上涨6.59%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.68%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206235753a1d999dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206235753a1d999dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","IKT"],"gpt_icon":0},{"id":"2489145458","title":"Inhibikase Therapeutics, Inc.盘中异动 下午盘快速下跌5.00%报2.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489145458","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489145458?lang=zh_cn&edition=full","pubTime":"2024-12-05 03:00","pubTimestamp":1733338836,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日03时00分，Inhibikase Therapeutics, Inc.股票出现波动，股价急速下挫5.00%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205030036ab5daa17&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205030036ab5daa17&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","IKT"],"gpt_icon":0},{"id":"2488770156","title":"Inhibikase Therapeutics, Inc.盘中异动 急速上涨6.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488770156","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488770156?lang=zh_cn&edition=full","pubTime":"2024-12-02 22:36","pubTimestamp":1733150184,"startTime":"0","endTime":"0","summary":"北京时间2024年12月02日22时36分，Inhibikase Therapeutics, Inc.股票出现异动，股价急速拉升6.16%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.05%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120222362498e4eb96&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120222362498e4eb96&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IKT","BK4139","LENZ"],"gpt_icon":0},{"id":"2487256383","title":"Inhibikase Therapeutics, Inc.盘中异动 股价大涨5.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2487256383","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2487256383?lang=zh_cn&edition=full","pubTime":"2024-11-29 22:31","pubTimestamp":1732890693,"startTime":"0","endTime":"0","summary":"北京时间2024年11月29日22时31分，Inhibikase Therapeutics, Inc.股票出现波动，股价快速上涨5.49%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.12%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112922313598e46642&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112922313598e46642&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","IKT"],"gpt_icon":0},{"id":"2486088148","title":"Inhibikase Therapeutics, Inc.盘中异动 大幅上涨5.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486088148","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486088148?lang=zh_cn&edition=full","pubTime":"2024-11-27 01:26","pubTimestamp":1732642011,"startTime":"0","endTime":"0","summary":"北京时间2024年11月27日01时26分，Inhibikase Therapeutics, Inc.股票出现波动，股价快速拉升5.54%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127012652971a8b0d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127012652971a8b0d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IKT","BK4139","LENZ"],"gpt_icon":0},{"id":"2486038844","title":"Inhibikase Therapeutics, Inc.盘中异动 早盘快速拉升5.19%报2.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486038844","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486038844?lang=zh_cn&edition=full","pubTime":"2024-11-25 22:33","pubTimestamp":1732545185,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日22时33分，Inhibikase Therapeutics, Inc.股票出现波动，股价大幅上涨5.19%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.06%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125223305a2548d36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125223305a2548d36&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IKT","LENZ","BK4139"],"gpt_icon":0},{"id":"2485329454","title":"Inhibikase Therapeutics, Inc.盘中异动 股价大涨5.97%报2.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485329454","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485329454?lang=zh_cn&edition=full","pubTime":"2024-11-23 01:39","pubTimestamp":1732297180,"startTime":"0","endTime":"0","summary":"北京时间2024年11月23日01时39分，Inhibikase Therapeutics, Inc.股票出现异动，股价急速拉升5.97%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.76%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112301394098e4435e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112301394098e4435e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IKT","BK4139","LENZ"],"gpt_icon":0},{"id":"2485549713","title":"Inhibikase Therapeutics, Inc.盘中异动 急速跳水6.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485549713","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485549713?lang=zh_cn&edition=full","pubTime":"2024-11-21 22:40","pubTimestamp":1732200053,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日22时40分，Inhibikase Therapeutics, Inc.股票出现异动，股价快速下挫6.57%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.32%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121224054971a7e35&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121224054971a7e35&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IKT","LENZ","BK4139"],"gpt_icon":0},{"id":"2485429125","title":"Inhibikase Therapeutics, Inc.盘中异动 股价大跌5.00%报1.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485429125","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485429125?lang=zh_cn&edition=full","pubTime":"2024-11-21 02:19","pubTimestamp":1732126743,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日02时19分，Inhibikase Therapeutics, Inc.股票出现异动，股价快速下挫5.00%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.52%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112102190498e43cb1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112102190498e43cb1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IKT","LENZ"],"gpt_icon":0},{"id":"2483804503","title":"Inhibikase Therapeutics, Inc.盘中异动 早盘急速下跌6.20%报2.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483804503","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483804503?lang=zh_cn&edition=full","pubTime":"2024-11-14 22:48","pubTimestamp":1731595732,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日22时48分，Inhibikase Therapeutics, Inc.股票出现波动，股价急速下跌6.20%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.57%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114224852abc16444&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114224852abc16444&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","IKT","BK4139"],"gpt_icon":0},{"id":"2482085765","title":"Inhibikase Therapeutics, Inc.盘中异动 股价大跌5.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482085765","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482085765?lang=zh_cn&edition=full","pubTime":"2024-11-12 22:32","pubTimestamp":1731421950,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日22时32分，Inhibikase Therapeutics, Inc.股票出现异动，股价快速跳水5.92%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112223231971a5fe5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112223231971a5fe5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IKT","BK4139","LENZ"],"gpt_icon":0},{"id":"2482181738","title":"Inhibikase Therapeutics, Inc.盘中异动 股价大涨6.59%报3.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482181738","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482181738?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:30","pubTimestamp":1731335425,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日22时30分，Inhibikase Therapeutics, Inc.股票出现异动，股价快速上涨6.59%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111122302598e41c2e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111122302598e41c2e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","IKT","BK4139"],"gpt_icon":0},{"id":"2482485034","title":"Inhibikase Therapeutics Inc   预计每股亏损37美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2482485034","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482485034?lang=zh_cn&edition=full","pubTime":"2024-11-09 00:04","pubTimestamp":1731081876,"startTime":"0","endTime":"0","summary":"   * Inhibikase Therapeutics Inc    预计将在11月12日公布截至2024年9月30日的业绩(预计)，季度收入将出现下降。*    * LSEG的分析师平均预计Inhibikase Therapeutics Inc每股亏损37美分。* 华尔街对 Inhibikase Therapeutics Inc 的 12 个月目标价中位数为 6.50 美元，高于其最新收盘价 2.78 美元。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IKT","LENZ"],"gpt_icon":0},{"id":"2481484101","title":"Inhibikase Therapeutics, Inc.盘中异动 早盘股价大涨6.29%报2.96美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481484101","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481484101?lang=zh_cn&edition=full","pubTime":"2024-11-08 22:32","pubTimestamp":1731076375,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日22时32分，Inhibikase Therapeutics, Inc.股票出现异动，股价大幅拉升6.29%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.42%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822325595bdef41&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822325595bdef41&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","IKT"],"gpt_icon":0},{"id":"2480058472","title":"Inhibikase Therapeutics, Inc.盘中异动 股价大跌5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480058472","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480058472?lang=zh_cn&edition=full","pubTime":"2024-11-04 22:52","pubTimestamp":1730731944,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日22时52分，Inhibikase Therapeutics, Inc.股票出现波动，股价快速下跌5.30%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104225224971a42c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104225224971a42c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","IKT","BK4139"],"gpt_icon":0},{"id":"2479203347","title":"Inhibikase Therapeutics, Inc.盘中异动 早盘快速下挫5.74%报2.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479203347","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479203347?lang=zh_cn&edition=full","pubTime":"2024-10-31 21:56","pubTimestamp":1730382997,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日21时56分，Inhibikase Therapeutics, Inc.股票出现波动，股价快速下挫5.74%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为2.37%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031215637a2023873&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031215637a2023873&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IKT","BK4139","LENZ"],"gpt_icon":0},{"id":"2479025810","title":"Inhibikase Therapeutics, Inc.盘中异动 股价大跌5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479025810","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479025810?lang=zh_cn&edition=full","pubTime":"2024-10-30 02:36","pubTimestamp":1730226985,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日02时36分，Inhibikase Therapeutics, Inc.股票出现异动，股价急速下挫5.11%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.10%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030023625971a2fec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030023625971a2fec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IKT","LENZ"],"gpt_icon":0},{"id":"2478486730","title":"Inhibikase Therapeutics, Inc.盘中异动 股价大涨6.73%报2.58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478486730","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478486730?lang=zh_cn&edition=full","pubTime":"2024-10-28 21:47","pubTimestamp":1730123273,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日21时47分，Inhibikase Therapeutics, Inc.股票出现波动，股价急速拉升6.73%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.58%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028214753a1f25614&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028214753a1f25614&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IKT","LENZ"],"gpt_icon":0},{"id":"2478493993","title":"Inhibikase Therapeutics, Inc.盘中异动 早盘大幅跳水5.95%报2.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478493993","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478493993?lang=zh_cn&edition=full","pubTime":"2024-10-25 22:11","pubTimestamp":1729865467,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日22时11分，Inhibikase Therapeutics, Inc.股票出现波动，股价急速跳水5.95%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.70%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025221107971a2575&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025221107971a2575&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","IKT"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.inhibikase.com","stockEarnings":[{"period":"1week","weight":0.163},{"period":"1month","weight":0.1146},{"period":"3month","weight":1.3955},{"period":"6month","weight":1.0316},{"period":"1year","weight":1.5887},{"period":"ytd","weight":1.5276}],"compareEarnings":[{"period":"1week","weight":0.0017},{"period":"1month","weight":0.0108},{"period":"3month","weight":0.1018},{"period":"6month","weight":0.117},{"period":"1year","weight":0.314},{"period":"ytd","weight":0.2722}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Inhibikase Therapeutics, Inc.于2010年6月3日注册为特拉华州公司。该公司是一家临床阶段制药公司，致力于开发针对帕金森氏病或PD以及大脑内外发生的相关疾病的疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.425952},{"month":2,"riseRate":0.5,"avgChangeRate":-0.118451},{"month":3,"riseRate":0.25,"avgChangeRate":0.045803},{"month":4,"riseRate":0,"avgChangeRate":-0.217435},{"month":5,"riseRate":0.75,"avgChangeRate":0.088455},{"month":6,"riseRate":0,"avgChangeRate":-0.283409},{"month":7,"riseRate":0.5,"avgChangeRate":-0.045361},{"month":8,"riseRate":0.5,"avgChangeRate":-0.009087},{"month":9,"riseRate":0,"avgChangeRate":-0.157472},{"month":10,"riseRate":0.5,"avgChangeRate":0.119822},{"month":11,"riseRate":0.75,"avgChangeRate":0.000349},{"month":12,"riseRate":0.5,"avgChangeRate":0.003789}],"exchange":"NASDAQ","name":"Inhibikase Therapeutics, Inc.","nameEN":"Inhibikase Therapeutics, Inc."},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Inhibikase Therapeutics, Inc.(IKT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Inhibikase Therapeutics, Inc.(IKT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Inhibikase Therapeutics, Inc.,IKT,Inhibikase Therapeutics, Inc.股票,Inhibikase Therapeutics, Inc.股票老虎,Inhibikase Therapeutics, Inc.股票老虎国际,Inhibikase Therapeutics, Inc.行情,Inhibikase Therapeutics, Inc.股票行情,Inhibikase Therapeutics, Inc.股价,Inhibikase Therapeutics, Inc.股市,Inhibikase Therapeutics, Inc.股票价格,Inhibikase Therapeutics, Inc.股票交易,Inhibikase Therapeutics, Inc.股票购买,Inhibikase Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Inhibikase Therapeutics, Inc.(IKT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Inhibikase Therapeutics, Inc.(IKT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}